GlassScriptPhysician profile
Adam C Ferro
NPI 1164841888
$4,895.03
in general payments reported to CMS, 2019-2025
41 companies · $771 in 2025
The $771 reported for 2025 was more than what 80% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.22 · 2020: $252 · 2021: $1,317 · 2022: $635 · 2023: $963 · 2024: $917 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,533 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,533.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $118.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,028.22 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $435.43 | 2020-2025 | Tagrisso, Lynparza |
| Siemens Medical Solutions USA, INC. | $293.98 | 2022-2025 | Varian Ethos Treatment Planning, Halcyon, Bravos Afterloader System |
| Regeneron Healthcare Solutions, INC. | $257.73 | 2022-2025 | Libtayo |
| E.R. Squibb & Sons, L.L.C. | $248.26 | 2020-2024 | Opdivo |
| Daiichi Sankyo INC. | $236.94 | 2021-2025 | Enhertu, Datroway |
| Teleflex LLC | $209.36 | 2024-2025 | Barrigel |
| Coherus Oncology, INC. | $178.90 | 2021-2025 | Loqtorzi |
| Merck Sharp & Dohme LLC | $173.00 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Takeda Pharmaceuticals U.S.A., INC. | $163.26 | 2020-2025 | Iclusig, Alunbrig, Ninlaro |
| Tersera Therapeutics LLC | $159.01 | 2023-2025 | Zoladex, Xermelo |
| Galvanize Therapeutics, INC | $149.27 | 2023 | Aliya System |
| Jazz Pharmaceuticals INC. | $141.97 | 2021-2024 | |
| Seagen INC. | $134.24 | 2020-2023 | Tukysa |
| Sumitomo Pharma America, INC. | $118.97 | 2024 | Orgovyx |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $114.70 | 2021-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $98.22 | 2020-2023 | Imbruvica |
| Janssen Biotech, INC. | $88.26 | 2022-2025 | Erleada, Rybrevant |
| Genentech USA, INC. | $70.03 | 2024-2025 | Tecentriq, Alecensa, Tecentriq Hybreza |
| Pfizer INC. | $65.59 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $56.79 | 2021 | |
| Novartis Pharmaceuticals Corporation | $46.33 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.99 | 2023-2024 | |
| Sobi, INC | $33.29 | 2022 | |
| Tactile Systems Technology INC | $28.55 | 2024 | Flexitouch Plus, Entre Plus |
| Stemline Therapeutics INC. | $27.11 | 2023 | Orserdu |
| Myovant Sciences INC. | $26.77 | 2022 | |
| Eisai INC. | $24.46 | 2019 | |
| Fennec Pharmaceuticals, INC. | $24.28 | 2024 | Pedmark |
| Incyte Corporation | $23.91 | 2025 | Zynyz, Monjuvi |
| Celgene Corporation | $23.45 | 2022 | |
| Amgen INC. | $22.71 | 2021 | |
| Icotec Medical INC. | $21.02 | 2025 | Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm |
| Exelixis INC. | $18.92 | 2023 | Cabometyx |
| Adaptive Biotechnologies Corporation | $18.16 | 2024 | Clonoseq |
| Deciphera Pharmaceuticals INC. | $17.89 | 2023 | Qinlock |
| Fortovia Therapeutics, INC. | $16.26 | 2020 | |
| Blueprint Medicines Corporation | $16.21 | 2021 | |
| Karyopharm Therapeutics INC. | $14.97 | 2022 | |
| Gilead Sciences, INC. | $14.86 | 2022 | |
| Novocure INC. | $14.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Ferro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.